Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections. - Wikidata - wikimedia - TriplyDB

Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections.

Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections.

http://www.wikidata.org/entity/Q34396053

about

Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy Host factors that contribute to recurrent staphylococcal skin infection Pathogenesis of Staphylococcus aureus abscesses The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens.Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation.Simple Wound Irrigation in the Postoperative Treatment for Surgically Drained Spontaneous Soft Tissue Abscesses: Study Protocol for a Prospective, Single-Blinded, Randomized Controlled Trial.Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation.Autophagy mediates tolerance to Staphylococcus aureus alpha-toxin.Apolipoprotein B48, the Structural Component of Chylomicrons, Is Sufficient to Antagonize Staphylococcus aureus Quorum-Sensing.Methicillin-resistant Staphylococcus aureus adaptation to human keratinocytes Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin Infection CD36 Is Essential for Regulation of the Host Innate Response to Staphylococcus aureus α-Toxin-Mediated Dermonecrosis.Prevention of Recurrent Staphylococcal Skin Infections Synergistic Action of Staphylococcus aureus α-Toxin on Platelets and Myeloid Lineage Cells Contributes to Lethal Sepsis The ever-emerging complexity of α-toxin's interaction with host cells Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis Importance of B Lymphocytes and the IgG-Binding Protein Sbi in Staphylococcus aureus Skin Infection.Innate Immune Memory Contributes to Host Defense against Recurrent Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus.The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies.Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs.α-Toxin Regulates Local Granulocyte Expansion from Hematopoietic Stem and Progenitor Cells in Staphylococcus aureus-Infected Wounds.Bacterial toxins: Offensive, defensive, or something else altogether?Neutralizing α-toxin accelerates healing of Staphylococcus aureus-infected wounds in normal and diabetic mice.Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314.Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection.

P2860

Q26752975-3F9137C9-3124-49AA-BFA2-7F5507D7B65E Q27005777-61FDEE98-05D3-4C4E-B5FE-DC0D5823DCC8 Q28080781-2293821E-22A6-4DEB-B0E6-F69AC14841EB Q29994694-CD043FFC-0DBD-44F7-9CBE-FFA2F5455BD3 Q30239977-9FC22155-C73F-4782-A618-D7ACDAF6875B Q33677615-FB681005-FF16-497A-A9FD-1BFF59C5EDF5 Q33690186-3DAA999C-044A-42F0-9701-8B902E07BD8D Q34922452-22821A12-03DE-417A-B8D9-9D9C385A0AEF Q35169008-8895F1BA-F488-484F-8126-DE6313149916 Q35356667-1F402BF7-0AB8-4E76-BB00-A89BC4D4921C Q35622488-D3CCB892-DF26-4D2D-B27F-1335CD62BF22 Q35677564-3A40C282-4873-42A7-8CBD-7DEB6C61915D Q35947359-366E4EDD-7483-44EB-80C2-C568FC55EEFA Q35988737-1A7DA8BA-24F8-4A13-AB2A-BBF82BD808DA Q36005464-5168F7EE-52F5-498A-B4F1-DB79BCAB0EE3 Q36274821-921A0161-65AE-452C-B24E-FB24F861C418 Q36306086-A0263923-4697-418B-BBB7-2501662B9D78 Q36609408-71BEB40F-7AED-4BB8-93C7-07C9DDECBB63 Q36636170-C089620A-B464-406A-92C4-BCCD900662DD Q36735408-6B3E5E99-0B6F-4B42-A068-86B7D71D36B6 Q37611964-4C5FE71B-06EC-4A97-A384-C8154DE415D1 Q38805996-23C54603-477F-4255-81A1-FEAB95FC5F2D Q39173330-FA1C6020-F4D8-454A-9051-24CB524326E3 Q40124323-7A5AD9F2-30D7-4FA4-B63A-88F97FD9BA3E Q41995627-EAD029AB-ED83-4C27-BD81-2BEB1D158B9E Q47193259-B3A3A524-965F-481F-8C1A-189A6CFC65D9 Q48319147-D2E10E7C-1BD1-4775-B0FD-DF161278E754 Q50199724-1903BA52-24A3-4671-80AA-FFC201E63B34

P2860

Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections.

http://www.wikidata.org/entity/Q34396053

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Targeting Staphylococcus aureu ...... in and soft-tissue infections.

@ast

Targeting Staphylococcus aureu ...... in and soft-tissue infections.

@en

Targeting Staphylococcus aureu ...... in and soft-tissue infections.

@nl

type

label

Targeting Staphylococcus aureu ...... in and soft-tissue infections.

@ast

Targeting Staphylococcus aureu ...... in and soft-tissue infections.

@en

Targeting Staphylococcus aureu ...... in and soft-tissue infections.

@nl

prefLabel

Targeting Staphylococcus aureu ...... in and soft-tissue infections.

@ast

Targeting Staphylococcus aureu ...... in and soft-tissue infections.

@en

Targeting Staphylococcus aureu ...... in and soft-tissue infections.

@nl

P1433

Q34396053-0538C41C-79A1-4BB5-BCC4-A576DD011396

P1476

Q34396053-FD0F6D6D-8A99-42C5-93A0-DB58F655FE5F

P2093

Q34396053-0EFC9D0B-83A8-484E-9685-A5B48D1E3065

Q34396053-248F8D91-5F83-4229-8E2B-31F7A194DD86

Q34396053-3B9C1F09-4438-40D4-9DCE-BD95A248F6A1

Q34396053-92821937-F3E5-4D6D-81D3-46D88478174A

Q34396053-97B2F215-4B8E-42F0-A71A-83282CE47421

Q34396053-F21AEDCB-B75F-4330-A83B-856704137EDE

Q34396053-F7456B59-4315-4DD5-9E55-718269E8F3EC

P2860

Q34396053-12A7499E-4560-488C-9B60-01225932EADE

Q34396053-1A07B73E-5571-4A76-816D-24E0FA42EAFF

Q34396053-2CA47E2F-0B85-46E8-90D7-6E0FED0C1BE0

Q34396053-3B3D5DCC-B13D-4244-BA09-63BDFD301155

Q34396053-40DEA5AD-7714-4C97-9FDE-6FC1E6621812

Q34396053-413A7168-8827-4E21-BCB9-4AC8B320B2BE

Q34396053-4817B4DD-6B11-4A75-BEAF-A2FC7E4CC2DB

Q34396053-60863ED5-2176-4589-96F3-0D69DBC69DFA

Q34396053-62871143-C6AB-4614-B978-7F83FE41DFA9

Q34396053-628A566C-C8FD-487D-9DD2-D651F773CC95

P304

Q34396053-06A5011A-A947-4F48-B44D-24207B8AF5AF

P31

Q34396053-A6D33AB9-ED65-4B41-9C04-41AB8A71BE30

P356

Q34396053-C11BAAA5-6DBE-4153-8960-8A4808272F55

P407

Q34396053-1AF77C61-EA49-41FC-A731-7BF9F85347ED

P433

Q34396053-3F16173C-3EC6-4D14-9518-D1040AABCF31

P478

Q34396053-BCC7A75D-F610-4CCC-B873-DE1C6A3AEBF0

P577

Q34396053-A4DE8F1F-FB44-4B8A-93B0-01A2B8A8C786

P5875

Q34396053-DAFF0978-A490-4DF9-8FD4-A17146BF58A1

P698

Q34396053-792B09F1-8E4B-4A33-ADBB-8E23EE619988

P932

Q34396053-0F4045E7-F92F-4A20-8205-175EA393DFE8

P356

P1433

The Journal of Infectious Diseases

P1476

Targeting Staphylococcus aureu ...... in and soft-tissue infections.

@en

P2093

Andrea C DeDent

http://www.w3.org/2001/XMLSchema#string

Bryan J Berube

http://www.w3.org/2001/XMLSchema#string

Georgia R Sampedro

http://www.w3.org/2001/XMLSchema#string

Hongyuan Cao

http://www.w3.org/2001/XMLSchema#string

Juliane Bubeck Wardenburg

http://www.w3.org/2001/XMLSchema#string

Michael J Gebhardt

http://www.w3.org/2001/XMLSchema#string

Russell E N Becker

http://www.w3.org/2001/XMLSchema#string

P2860

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic

Vaccine protection against Staphylococcus aureus pneumonia

Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia

Staphylococcus aureus α-toxin: nearly a century of intrigue

Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury

The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).

Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection

Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Alpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infection.

Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis model.

P304

1012-1018

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIU223

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

210

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261751858

http://www.w3.org/2001/XMLSchema#string

P698

24740631

http://www.w3.org/2001/XMLSchema#string

P932

4207862

http://www.w3.org/2001/XMLSchema#string